Device Trial Radar · NCT04086550
Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
Last checked: Nov 19, 2026Latest source record: Jun 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
228
Actual
Start
May 20, 2021
Primary completion
Feb 13, 2024
Study completion Feb 13, 2024
Sponsor
- Lead sponsor
- Polyganics BVNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 11, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure to show noninferiority compared to a control group.
Conditions
- Cerebrospinal Fluid Leak
Interventions
LIQOSEALDevice
Adjunctive bioresorbable patch
DuraSeal, AdherusDevice
synthetic absorbable sealants
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite endpoint defined as successful dural repair without any of the following compared to the control group: intra-operative CSF leakage percutaneous CSF leak significant pseudomeningocele wound infectionTime frame: 30 days
Locations
17 sites in 7 countries. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Baptist Health
Jacksonville, Florida
Mayo Clinic
Jacksonville, Florida
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.